{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:32Z","timestamp":1791919592592,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010037","name":"Chongqing Youth Science and Technology Talent Training Project","doi-asserted-by":"publisher","award":["CSTC2024YCJH-BGZXM0011"],"award-info":[{"award-number":["CSTC2024YCJH-BGZXM0011"]}],"id":[{"id":"10.13039\/501100010037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300561"],"award-info":[{"award-number":["82300561"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["CSTB2022NSCQ-MSX0174"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX0174"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.canlet.2025.217805","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T02:13:18Z","timestamp":1747620798000},"page":"217805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Aberrant PLAC8 expression characterizes glioblastoma with temozolomide resistance and an immunosuppressive microenvironment"],"prefix":"10.1016","volume":"625","author":[{"given":"Han","family":"She","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Yu","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunjia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxiang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217805_bib1","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41467-021-21117-3","article-title":"Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma","volume":"12","author":"Jung","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.217805_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-024-00516-y","article-title":"Glioma","volume":"10","author":"Weller","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.canlet.2025.217805_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaoncol.2022.2844","article-title":"World Health organization 2021 classification of central nervous system tumors and implications for therapy for adult-type gliomas: a review","volume":"8","author":"Berger","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2025.217805_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s13311-022-01249-0","article-title":"Major features of the 2021 WHO classification of CNS tumors","volume":"19","author":"Smith","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.canlet.2025.217805_bib5","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.3390\/ijms24087047","article-title":"Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets","volume":"24","author":"Ignacio Erices","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217805_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3171\/2024.5.JNS24393","article-title":"Long-term survivors in 976 supratentorial glioblastoma, IDH-wildtype patients","volume":"142","author":"Aboubakr","year":"2024","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.canlet.2025.217805_bib7","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.7150\/thno.82005","article-title":"Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment","volume":"13","author":"Iturrioz-Rodr\u00edguez","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2025.217805_bib8","article-title":"Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Singh Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2025.217805_bib9","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.3390\/ijms25063217","article-title":"A review of approaches to potentiate the activity of temozolomide against glioblastoma to overcome resistance","volume":"25","author":"Karve","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217805_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116588","article-title":"Novel strategies to overcome chemoresistance in human glioblastoma","volume":"230","author":"Tang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217805_bib11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/neuonc\/noae028","article-title":"Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide","volume":"26","author":"Cheng","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2025.217805_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40425-018-0367-1","article-title":"Pan-cancer adaptive immune resistance as defined by the tumor inflammation signature (TIS): results from the cancer genome Atlas (TCGA)","volume":"6","author":"Danaher","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.217805_bib13","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bja.2024.09.031","article-title":"Kappa opioid receptor internalisation-induced p38 nuclear translocation suppresses glioma progression","volume":"134","author":"Li","year":"2025","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.canlet.2025.217805_bib14","first-page":"186","article-title":"Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma","volume":"19","author":"Barone","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2025.217805_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40364-021-00329-1","article-title":"Multifaced roles of PLAC8 in cancer","volume":"9","author":"Misha","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2025.217805_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2017.08.023","article-title":"Induction of Plac8 promotes pro-survival function of autophagy in cadmium-induced prostate carcinogenesis","volume":"408","author":"Kolluru","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217805_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107922","article-title":"Genotoxic therapy and resistance mechanism in gliomas","volume":"228","author":"Lang","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2025.217805_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216593","article-title":"Neovascularization directed by CAVIN1\/CCBE1\/VEGFC confers TMZ-resistance in glioblastoma","volume":"582","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217805_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217107","article-title":"Unveiling the role of TAGLN2 in glioblastoma: from proneural-mesenchymal transition to Temozolomide resistance","volume":"598","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217805_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101112","article-title":"Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane","volume":"76","author":"Zhang","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2025.217805_bib21","doi-asserted-by":"crossref","first-page":"gkae1320","DOI":"10.1093\/nar\/gkae1320","article-title":"Single-nucleotide-resolution genomic maps of O6-methylguanine from the glioblastoma drug temozolomide","volume":"53","author":"Kubitschek","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2025.217805_bib22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40001-024-01754-2","article-title":"CD133 significance in glioblastoma development: in silico and in vitro study","volume":"29","author":"Abdoli Shadbad","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.canlet.2025.217805_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj7706","article-title":"Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells","volume":"10","author":"Park","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2025.217805_bib24","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41419-022-05175-z","article-title":"CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis","volume":"13","author":"Luo","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217805_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s40001-023-01370-6","article-title":"Drug metabolism-related gene ABCA1 augments temozolomide chemoresistance and immune infiltration abundance of M2 macrophages in glioma","volume":"28","author":"Yan","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.canlet.2025.217805_bib26","article-title":"Enhancing glioma-specific drug delivery through self-assembly of macrophage membrane and targeted polymer assisted by low-frequency ultrasound irradiation","volume":"26","author":"Lin","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.canlet.2025.217805_bib27","article-title":"Brain-targeting drug delivery systems: the state of the art in treatment of glioblastoma","volume":"30","author":"Sun","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.canlet.2025.217805_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115726","article-title":"Modulating MGMT expression through interfering with cell signaling pathways","volume":"215","author":"Bai","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2025.217805_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1158\/1078-0432.CCR-22-0611","article-title":"A sequential targeting strategy interrupts AKT-driven subclone-mediated progression in glioblastoma","volume":"29","author":"Kebir","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217805_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41420-023-01462-6","article-title":"Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth","volume":"9","author":"Schaf","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.canlet.2025.217805_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005668","article-title":"Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer","volume":"10","author":"Mao","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.217805_bib32","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1111\/jcmm.16706","article-title":"PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2025.217805_bib33","first-page":"17","article-title":"Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review","volume":"4","author":"Singh","year":"2021","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.canlet.2025.217805_bib34","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/ijms23031353","article-title":"Wnt and PI3K\/Akt\/mTOR survival pathways as therapeutic targets in glioblastoma","volume":"23","author":"Barzegar Behrooz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.217805_bib35","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/cac2.12361","article-title":"An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment","volume":"42","author":"Verdugo","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.canlet.2025.217805_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3892\/ijo.2022.5359","article-title":"Signaling pathways and therapeutic approaches in glioblastoma multiforme","volume":"60","author":"Khabibov","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2025.217805_bib37","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1158\/1078-0432.CCR-22-3179","article-title":"Protein Kinase B (PKB\/AKT) protects IDH-mutated glioma from ferroptosis via Nrf2","volume":"29","author":"Liu","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217805_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217805_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathmechdis-051122-110348","article-title":"Role of the microenvironment in glioma pathogenesis","volume":"19","author":"Jayaram","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.canlet.2025.217805_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163447","article-title":"Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment","volume":"133","author":"Arrieta","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217805_bib41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","article-title":"Conserved pan-cancer microenvironment subtypes predict response to immunotherapy","volume":"39","author":"Bagaev","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217805_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/1574892817666220804142633","article-title":"Bourgeoning cancer targets","volume":"18","author":"Kriplani","year":"2022","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.canlet.2025.217805_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216938","article-title":"Comprehensive molecular characterization of long-term glioblastoma survivors","volume":"593","author":"Xu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217805_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1207551","article-title":"PLAC8 is an innovative biomarker for immunotherapy participating in remodeling the immune microenvironment of renal clear cell carcinoma","volume":"13","author":"Sun","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2025.217805_bib45","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbrc.2019.06.121","article-title":"PLAC8 overexpression correlates with PD-L1 upregulation and acquired resistance to chemotherapies in gallbladder carcinoma","volume":"516","author":"Gong","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2025.217805_bib46","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103790","article-title":"Microglia promote glioblastoma via mTOR-mediated immunosuppression of the tumour microenvironment","volume":"39","author":"Dumas","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2025.217805_bib47","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jnci\/djab068","article-title":"Predictive biomarkers: progress on the road to personalized cancer immunotherapy","volume":"113","author":"Emens","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.canlet.2025.217805_bib48","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ccell.2023.07.011","article-title":"Neoadjuvant immune checkpoint blockade: a window of opportunity to advance cancer immunotherapy","volume":"41","author":"Topalian","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217805_bib49","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.217805_bib50","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163447","article-title":"Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment","volume":"133","author":"Arrieta","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217805_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216955","article-title":"Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: a focus on brain malignancies","volume":"593","author":"Afshari","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217805_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217185","article-title":"Suppressive immune microenvironment and CART therapy for glioblastoma: future prospects and challenges","volume":"600","author":"Lu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217805_bib53","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40364-022-00378-0","article-title":"The role of biomarkers in personalized immunotherapy","volume":"10","author":"Sankar","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.canlet.2025.217805_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41571-023-00830-6","article-title":"Computational immunogenomic approaches to predict response to cancer immunotherapies","volume":"21","author":"Addala","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.217805_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1394003","article-title":"Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy","volume":"15","author":"Bulashevska","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525003726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:35:04Z","timestamp":1762288504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525003726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":55,"alternative-id":["S0304383525003726"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217805","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant PLAC8 expression characterizes glioblastoma with temozolomide resistance and an immunosuppressive microenvironment","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217805"}}